Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 3;46(1):6-14.
doi: 10.1093/eurheartj/ehae419.

Family matters: health policies to tackle cardiomyopathies across Europe

Collaborators, Affiliations

Family matters: health policies to tackle cardiomyopathies across Europe

Iacopo Olivotto et al. Eur Heart J. .

Erratum in

No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of measures that national-level policy and health system decision-makers should implement to improve care and support for patients affected by cardiomyopathies and other inherited cardiovascular diseases. These include measures at key stages of the care pathway (diagnosis, referral, and disease management) and those that apply throughout all stages (holistic support for, and empowerment of patients and carers, and research and innovation)

References

    1. Luengo-Fernandez R, Walli-Attaei M, Gray A, Torbica A, Maggioni AP, Huculeci R, et al. Economic burden of cardiovascular diseases in the European Union: a population-based cost study. Eur Heart J 2023;44:4752–67.10.1093/eurheartj/ehad583 - DOI - PMC - PubMed
    1. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503–26. 10.1093/eurheartj/ehad194 - DOI - PubMed
    1. McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol 2021;18:22–36. 10.1038/s41569-020-0428-2 - DOI - PubMed
    1. Cardiomyopathies Matter: a Policy Roadmap to improve cardiomyopathy detection and care in Europe. 2022. www.cardiomyopathiesmatter.org (14 March 2024, date last accessed).
    1. Argirò A, Ding J, Adler E. Gene therapy for heart failure and cardiomyopathies. Rev Esp Cardiol (Engl Ed) 2023;76:1042–54. 10.1016/j.rec.2023.06.009 - DOI - PubMed

Grants and funding